GEV Stock Analysis: GE Vernova | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 250.873m USD | 12M Return: 51.3% | US36828A1016 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.88B
Qual. Beats: 0
Rev. Trend: 98.9%
Qual. Beats: 1
Warnings
Tailwinds
No distinct edge detected
Seasonality 2.3 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
GE Vernova (NYSE: GEV) is a U.S.-based energy company, headquartered in Cambridge, Massachusetts, and incorporated in 2023 ahead of its spin-off from General Electric in early 2024. The company operates across three segments: Power (gas, nuclear, hydro, and steam technologies), Wind (onshore and offshore turbines and blades), and Electrification (grid solutions, power conversion, software, and solar and storage technologies). Its products and services span the full electricity value chain, from generation through transmission, distribution, conversion, storage, and consumption, with operations in the United States, Europe, Asia, the Middle East, and Africa.
As a major supplier of power generation and grid equipment, GE Vernova serves industrial, government, and utility customers globally. It is classified in the GICS Utilities sector under Independent Power Producers & Energy Traders, reflecting its role in supplying technologies rather than directly selling electricity to end users. The companys portfolio positions it in key areas of the energy transition, including renewable generation, nuclear power, and grid modernization needed to integrate variable energy sources.
- Gas turbine backlog surges on AI data center power demand
- Wind segment losses narrow as pricing and execution improve
- Electrification orders accelerate amid grid modernization spending
| Net Income: 9.53b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 10.29 > 1.0 |
| NWC/Revenue: -20.30% < 20% (prev 2.59%; Δ -22.89% < -1%) |
| CFO/TA 0.17 > 3% & CFO 14.1b > Net Income 9.53b |
| Net Debt (-8.32b) to EBITDA (3.00b): -2.77 < 3 |
| Current Ratio: 0.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (270.0m) vs 12m ago -2.17% < -2% |
| Gross Margin: 20.21% > 18% (prev 18.02%; Δ 2.19% > 0.5%) |
| Asset Turnover: 61.80% > 50% (prev 69.00%; Δ -7.20% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: -0.10 (Total Current Assets 47.4b - Total Current Liabilities 55.8b) / Total Assets 80.8b |
| B: 0.14 (Retained Earnings 11.3b / Total Assets 80.8b) |
| C: 0.03 (EBIT TTM 1.80b / Avg Total Assets 66.9b) |
| D: 0.18 (Book Value of Equity 12.0b / Total Liabilities 67.7b) |
| Altman-Z'' = 0.14 = B |
| DSRI: 1.11 (Receivables 20.6b/16.4b, Revenue 41.4b/36.6b) |
| GMI: 0.89 (GM 18.02% / 20.21%) |
| AQI: 1.32 (AQ_t 0.32 / AQ_t-1 0.24) |
| SGI: 1.13 (Revenue 41.4b / 36.6b) |
| TATA: -0.06 (NI 9.53b - CFO 14.1b) / TA 80.8b) |
| Beneish M = -2.76 (Cap -4..+1) = A |
As of September 15, 2026, the stock is trading at USD 957.27 with a total of 1,175,204 shares traded. Over the past week, the price has changed by +1.64%, over one month by -5.40%, over three months by +5.62% and over the past year by +51.30%.
Current recommended Stop Loss: 866.80 (which is 9.5% or 2.2 ATR below the current price).
GE Vernova has received a consensus analysts rating of 4.19. Therefore, it is recommended to buy GEV.
- StrongBuy: 16
- Buy: 8
- Hold: 7
- Sell: 0
- StrongSell: 1
| Analysts Target Price | 1236.4 | 29.2% |
P/E Trailing = 27.0287
P/E Forward = 38.1679
P/S = 6.0646
P/B = 20.9788
P/EG = 1.8359
Revenue TTM = 41.4b USD
EBIT TTM = 1.80b USD
EBITDA TTM = 3.00b USD
Long Term Debt = 2.79b USD (from longTermDebt, last quarter)
Short Term Debt = 1.17b USD (from shortTermDebt, last quarter)
Debt = 4.80b USD (from shortLongTermDebtTotal, last quarter) + Leases 844.0m
Net Debt = -8.32b USD (calculated: Debt 4.80b - CCE 13.1b)
Enterprise Value = 243b USD (251b + Debt 4.80b - CCE 13.1b)
Interest Coverage Ratio = unknown (Ebit TTM 1.80b / Interest Expense TTM 0.0)
EV/FCF = 19.50x (Enterprise Value 243b / FCF TTM 12.4b)
FCF Yield = 5.13% (FCF TTM 12.4b / Enterprise Value 243b)
FCF Margin = 30.07% (FCF TTM 12.4b / Revenue TTM 41.4b)
Net Margin = 23.03% (Net Income TTM 9.53b / Revenue TTM 41.4b)
Gross Margin = 20.21% ((Revenue TTM 41.4b - Cost of Revenue TTM 33.0b) / Revenue TTM)
Gross Margin QoQ = 21.26% (prev 19.08%)
Tobins Q-Ratio = 3.00 (Enterprise Value 243b / Total Assets 80.8b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 4.80b)
Taxrate = 29.84% (276.0m / 925.0m)
NOPAT = 1.26b (EBIT 1.80b * (1 - 29.84%))
Current Ratio = 0.85 (Total Current Assets 47.4b / Total Current Liabilities 55.8b)
Debt / Equity = 0.40 (Debt 4.80b / totalStockholderEquity, last quarter 12.0b)
Debt / EBITDA = -2.77 (Net Debt -8.32b / EBITDA 3.00b)
Debt / FCF = -0.67 (Net Debt -8.32b / FCF TTM 12.4b)
Total Stockholder Equity = 11.4b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.24% (Net Income 9.53b / Total Assets 80.8b)
RoE = 83.40% (Net Income TTM 9.53b / Total Stockholder Equity 11.4b)
RoCE = 12.67% (EBIT 1.80b / Capital Employed (Equity 11.4b + L.T.Debt 2.79b))
RoIC = 5.25% (NOPAT 1.26b / Invested Capital 24.1b)
WACC = 12.83% (E(251b)/V(256b) * Re(13.08%) + D(4.80b)/V(256b) * Rd(0.0%) * (1-Tc(0.30)))
Discount Rate = 13.08% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -42.13 | Cagr: -0.34%
[DCF] Terminal Value 64.88% ; FCFF base≈8.55b ; Y1≈9.80b ; Y5≈14.4b
[DCF] Fair Price = 483.8 (EV 121b - Net Debt -8.32b = Equity 129b / Shares 266.3m; r=12.83% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.20 | # QB: 0
Revenue Correlation: 98.87 | Revenue CAGR: 7.02% | SUE: 1.05 | # QB: 1
EPS current Quarter (2026-09-30): EPS=4.17 | Chg30d=-0.79% | Revisions=+13% | Analysts=14
EPS current Year (2026-12-31): EPS=30.74 | Chg30d=+0.02% | Revisions=-10% | GrowthEPS=+73.8% | GrowthRev=+21.5%
EPS next Year (2027-12-31): EPS=24.69 | Chg30d=-0.64% | Revisions=+62% | GrowthEPS=-19.7% | GrowthRev=+13.9%
[Analyst] Revisions Ratio: +28% (up=33, down=18)